Togo vs Uzbekistan: Tuberculosis patients who tested positive for HIV
Togo
332 patients
in 2021
Uzbekistan
441 patients
in 2021
Togo rank
59th
Uzbekistan rank
56th
Tuberculosis patients who tested positive for HIV over time
- Togo
- Uzbekistan
How they compare
Uzbekistan currently reports 441 patients against 332 patients in Togo, a difference of 109 patients.
That makes Uzbekistan's figure about 1.3 times Togo's.
The two have swapped places 4 times across 16 shared years of data; in 2005 it was Uzbekistan ahead.
Togo ranks 59th and Uzbekistan ranks 56th of 201 countries.
Uzbekistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Togo | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 130.25 patients | 282.75 patients | 152.5 patients | Uzbekistan |
| 2010s | 546.3 patients | 758.7 patients | 212.4 patients | Uzbekistan |
| 2020s | 370.5 patients | 410 patients | 39.5 patients | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients who tested positive for hiv, Togo or Uzbekistan?
- Uzbekistan, at 441 patients against 332 patients in Togo as of 2021.
- What is the difference in tuberculosis patients who tested positive for hiv between Togo and Uzbekistan?
- 109 patients, with Uzbekistan ahead.
- How many years of comparable data are there for Togo and Uzbekistan?
- 16 years are reported by both, from 2005 to 2021.
- How do Togo and Uzbekistan rank globally for tuberculosis patients who tested positive for hiv?
- Togo ranks 59th and Uzbekistan ranks 56th of 201 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients who tested positive for HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of tuberculosis (new and relapsed) patients that tested positive for HIV.